Niederer Kraft Frey (“NKF”) promotes Lukas Fahrländer (pictured) to senior associate, effective 1 July 2024. Lukas Fahrländer Lukas Fahrländer is a member of the banking, finance & regulatory team. He advises Swiss and international
Tags :NKF
Niederer Kraft Frey (“NKF”) advised SIX listed CPH Chemie + Papier Holding (CPH) on the separation of its paper manufacturing business and related real estate in Perlen from its chemistry and packaging activities by way of
Niederer Kraft Frey (“NKF”) advised UBS in its capacity as sole global coordinator and sole bookrunner on Warteck Invest’s CHF 94.7 million capital increase by way of a rights offering launched on 3 June 2024, in which
Niederer Kraft Frey (“NKF”) advised GreenState, a swiss vertical farming company, on its acquisition of Yasai, advised by Walder Wyss. The combination of GreenState and Yasai’s technologies will result in the creation of a
Niederer Kraft Frey (NKF) advised Herman Rosen on the sale of part of the Rosen Group to Partners Group as well as Mr. Rosen’s re-investment. NKF’s team Corporate / M&A partner Andreas
Niederer Kraft Frey (NKF) advised EDF on the acquisition of GE Vernova’s steam nuclear activities, covering conventional island equipment for nuclear power plants excluding servicing activities in the Americas. As part of the EDF,
Niederer Kraft Frey (NKF) acted as an advisor for Index Ventures on its investment in EthonAI. EthonAI, a pioneer in AI-powered manufacturing analytics, has closed a $16.5 million (CHF 15 million) Series A financing led by Index
NKF for UBS Switzerland’s loan facility to Arbonia
Niederer Kraft Frey (NKF) advised UBS Switzerland on a 100 million bridge loan facility for Arbonia’s acquisition of the Dimoldura Group. Arbonia is a building components supplier listed on the SIX Swiss Exchange with annual
by claudia la via When the financial support measures taken by the Swiss Federal Council to support businesses suffering from the effect of the coronavirus pandemic came to an end in 2022, the number of bankruptcies
Walder Wyss advised the funds managed by Perceptive Advisor, a privately owned hedge fund sponsor investing in biotechnology and life sciences sectors, on the secured term loan financing for up USD 50,000,000 granted to Sophia Genetics,